BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-295@pharmaconomics
DTSTAMP:20260707T003607Z
DTSTART;VALUE=DATE:20260729
DTEND;VALUE=DATE:20260730
SUMMARY:CAPR AdCom — Deramiocel
DESCRIPTION:An FDA advisory committee reviews Deramiocel for Duchenne muscular dystrophy around Jul 29\, 2026. The panel's public vote often front-runs the agency's final verdict — and the share price.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1133869/000110465926078327/capr-20260626xex99d1.htm\n\nTrack it: https://pharmaconomics.com/e/295
URL:https://pharmaconomics.com/e/295
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:CAPR catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR